Century Therapeutics, Inc.

NASDAQ:IPSC

1.65 (USD) • At close September 18, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Omzet 0.7710.8550.2680.1480.0991.720.5212.2241.3961.05800000000
Kosten van de omzet 3.4623.2263.5521.7872.4092.173.3832.7741.66821.1961.8851.0440.9350.9480000
Brutowinst -2.691-2.371-3.284-1.639-2.31-0.45-2.862-0.55-0.272-20.138-1.885-1.044-0.935-0.9480000
Brutowinstmarge -3.49-2.773-12.254-11.074-23.333-0.262-5.493-0.247-0.195-19.03400000000
Onderzoek- en ontwikkelingskosten 23.75820.19522.29622.78822.72724.89925.58525.89824.49431.19621.79619.54518.93315.37412.44210.8128.4847.943
Algemene en administratieve kosten 8.3068.7438.5898.9868.2298.9028.2428.0648.2537.2986.1776.2824.0882.6882.8162.3192.312.05
Verkoop- en marketingkosten 0.7820-3.552000000000000000
Verkoop-, algemene en administratieve kosten 9.0888.7435.0378.9868.2298.9028.2428.0648.2537.2986.1776.2824.0882.6882.8162.3192.312.05
Overige kosten -0.0120.011-0.0150.012-0.186-0.1942.0691.3870100000.0280000.32
Bedrijfskosten 32.84628.93827.33331.77430.95633.80133.82733.96232.74738.49427.97325.82723.02118.06215.25813.13110.7949.993
Bedrijfsresultaat -35.537-31.309-30.617-35.626-35.077-32.081-33.306-31.738-31.351-37.436-27.973-25.827-23.021-18.062-15.258-13.131-15.516-9.993
Bedrijfsresultaat ratio -46.092-36.619-114.243-240.716-354.313-18.652-63.927-14.271-22.458-35.38400000000
Totaal overige inkomsten en kosten netto 4.3523.248-9.65-3.988-4.4062.0251.6561.0140.381-0.061-5.456-0.182-0.2520.0280.7040.061-4.7220.32
Inkomen voor belasting -31.185-28.061-40.267-32.128-32.341-30.056-31.65-30.724-30.97-37.497-28.151-26.009-23.273-18.348-15.531-13.07-15.301-9.673
Inkomen voor belasting ratio -40.447-32.82-150.25-217.081-326.677-17.474-60.749-13.815-22.185-35.44100000000
Belastingkosten 0.0220.001-0.8690.5920.951.2080.0320.0250.0180.0160.0430.063-0.010.3421.040.10600.32
Nettowinst -31.207-28.062-39.398-32.72-33.291-31.264-31.682-30.749-30.988-37.513-28.194-26.009-23.273-18.348-15.531-13.07-15.301-9.673
Nettowinstmarge -40.476-32.821-147.007-221.081-336.273-18.177-60.81-13.826-22.198-35.45700000000
WPA (Winst Per Aandeel) -0.38-0.45-0.66-0.55-0.56-0.53-0.54-0.53-0.54-0.66-0.52-0.48-0.43-0.33-0.37-0.31-0.37-0.23
Verwaterde WPA -0.38-0.45-0.66-0.55-0.56-0.53-0.54-0.53-0.54-0.66-0.52-0.48-0.43-0.33-0.37-0.31-0.37-0.23
EBITDA -32.075-28.083-27.065-28.128-24.751-29.652-28.494-27.654-29.048-36.099-27.601-24.72-22.096-17.316-14.685-12.615-10.297-9.473
EBITDA ratio -41.602-32.846-100.989-190.054-250.01-17.24-54.691-12.434-20.808-34.1200000000